This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Raymond R. Townsend, MD; O. Bryan Holland, MD

Arch Intern Med. 1990;150(6):1175-1183.

Abstract
• In recent years there has been increased discussion about goals of antihypertensive therapy other than blood pressure reduction. The development of angiotensin-converting enzyme inhibitors has provided a class of drugs with a very low sideeffect profile. However, single-drug therapy is effective in only about half of hypertensive patients. In the past, diuretics have traditionally been used as the initial or second antihypertensive. Increasingly, diuretic therapy is being avoided, and other antihypertensive combinations are being used. In controlled trials, combination converting enzyme inhibitor-diuretic therapy is effective in about 85% of patients. This synergistic combination allows the diuretic dose to be reduced so that the adverse effects and metabolic complications are minimized. At this time, the combination of converting enzyme inhibitor and diuretic provides an ideal choice in terms of efficacy, compliance, side effects, and cost.

(Arch Intern Med. 1990;150:1175-1183)

Author Affiliations
From the Department of Internal Medicine, University of Texas Medical Branch, Galveston.

Footnotes
Accepted for publication December 27,1989.

Reprint requests to Room 4.156 OJSH E-72, University of Texas Medical Branch, Galveston, TX 77550 (Dr Townsend).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thiazide Effects and Adverse Effects: Insights From Molecular Genetics
Ellison and Loffing
Hypertension 2009;54:196-202.
FULL TEXT  

Hypertension and the Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2004;38:103-119.
ABSTRACT  

Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency
Tonelli et al.
Nephrol Dial Transplant 2002;17:1426-1433.
ABSTRACT | FULL TEXT  

Slowing the progression of chronic renal insufficiency
Tonelli et al.
CMAJ 2002;166:906-907.
FULL TEXT  

Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment
Doucet et al.
Journal of Renin-Angiotensin-Aldosterone System 2001;2:107-111.
ABSTRACT  

A Diuretic Is More Effective Than a ß-Blocker in Hypertensive Patients Not Controlled on Amlodipine and Lisinopril
Antonios et al.
Hypertension 1996;27:1325-1328.
ABSTRACT | FULL TEXT  

Remembering the Lessons of Basic Pharmacology
Fagan
Arch Intern Med 1994;154:1430-1431.
ABSTRACT  

A Multifactorial Trial Design to Assess Combination Therapy in Hypertension: Treatment With Bisoprolol and Hydrochlorothiazide
Frishman et al.
Arch Intern Med 1994;154:1461-1468.
ABSTRACT  

Antihypertensive Effectiveness of Low-Dose Lisinopril-Hydrochlorothiazide Combination: A Large Multicenter Study
Chrysant and The Lisinopril-Hydrochlorothiazide Group
Arch Intern Med 1994;154:737-743.
ABSTRACT